RCT to evaluate a new wound care product
Partners/Funding body: Clinical Trials Unit, University of Auckland and CoDa Therapeutics
Project description: The NOVEL trial, is investigating whether NexagonTM is a safe and effective treatment for venous leg ulcers when used with standard compression bandaging. The trial is a prospective, randomized, double blind, placebo controlled trial being conducted at five sites in New Zealand and three sites in the USA. Participation period for the trial is for approximately 14 weeks. The trial involves participants receiving the study drug as a topical agent on three occasions over four weeks in addition to standardised dressings and compression bandaging. The main endpoints are ulcer healing and safety.
Project update: the project completed February 2010
Project outcomes: a project report will be published in-house once the trial is completed. Further clinical trials in 2011 are planned by CoDa Therapeutics.
Further information: Lead investigator at Nurse Maude – Catherine Hammond, Clinical Nurse Specialist Wound CareEmail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it